How well are randomized controlled trials reported in the dermatology literature?

Archives of Dermatology

Volumn 136, Issue 3, 2000, Pages 381-385

  Adetugbo, Kayode ^a,b   Williams, Hywel ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DERMATOLOGY; DOCUMENTATION; HUMAN; MEDICAL LITERATURE; METHODOLOGY; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SAMPLE;

EID: 0034098108     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.136.3.381     Document Type: Article

References (31)

1. Cook DJ, Guyatt GH, Laupacis A, Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest. 1992;102(suppl 4): 305S-311S.
2. Sibbald B, Roland M, Understanding controlled trials. BMJ. 1998;316:201.
3. Kunz R, Oxman AD. The unpredictability paradox. BMJ. 1998;317:1185-1190.
4. Chalmers TC, Matta RJ, Smith H Jr, Kunzler AM. Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction. N Engl J Med. 1977;297:1091-1096.
5. Sacks H, Chalmers TC, Smith H Jr. Randomized versus historical controls for clinical trials. Am J Med. 1982;72:233-240.
6. Cochrane AL. Effectiveness and Efficiency: Random Reflections on Health Services. London. England: Nuffield Provincial Hospitals Trust; 1972.
7. Hlatky MA, Califf RM, Harrell FE Jr, Lee KL, Mark DB, Pryor DB. Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery. J Am Coll Cardiol. 1988;11:237-245.
8. Keine H. A critique of the double blind clinical trial. Altern Ther. 1996;2:59-64.
9. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ. 1996;312:215-218.
10. Hemminki E. Problems of clinical trials as evidence of therapeutic effectiveness. Soc Sci Med. 1982;16:711-712.
11. Moher D, Dulberg CS, Wells GA. Statistical power sample size, and their reporting in randomized controlled trials. JAMA. 1994;272:122-124.
12. Gray JAM. Evidence-Based Healthcare. New York, NY: Churchill Livingstone Inc; 1997:78-86.
13. Khan KS, Daya S, Jadad A. The importance of quality of primary studies in producing unbiased systematic reviews. Arch Intern Med. 1996;156:661-666.
14. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. JAMA. 1995;273:408-412.
15. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. JAMA. 1996;276:637-639.
16. Williams H, Adetugbo K, Po AL, Naldi L, Diepgen T, Murrell D. The Cochrane Skin Group. Arch Dermatol. 1998;134:1620-1626.
17. Cochrane Collaboration. The CochraneControlled Trials Register [Cochrane Review on CD-ROM]. Oxford, England: Cochrane Library, Update Software; 1998:issue 4.
18. Cochrane Hand Search Manual. Available at: http://hiru.mcmaster.ca/cochrane /registry/handsrch/hsmanual.htm. Accessed January 5, 2000.
19. Bigby M, Stern RS, Bigby JA. An evaluation of method reporting and use in clinical trials in dermatology. Arch Dermatol. 1985;121:1394-1399.
20. Williams HC, Seed P. Inadequate size of "negative" clinical trials in dermatology. Br J Dermatol. 1993;128:317-326.
21. Dickersin K, Larson K. Appendix 5b: definitions of RCTs and CCTs. In: Mulrow CD, Oxman AD, eds. Cochrane Collaboration Handbook [database on CD-ROM]. Oxford, England: Cochrane Library, Update Software;1998;version 4.
22. Schulz KF, Chalmers I, Grimes DA, Altman DG. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA. 1994;272:125-128.
23. Liberati A, Himel HN, Chalmers TC. A quality assessment of randomized controlled trials of primary treatment of breast cancer. J Clin Oncol. 1986;4:942-951.
24. Meinert CL. Beyond CONSORT. JAMA. 1998;279:1487-1489
25. Thornley B, Adams C. Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ. 1998;317:1181-1184.
26. DerSimonian R, Charette LJ, McPeek B, Mosteller F. Reporting on methods in clinical trials. N Engl J Med. 1982;307:1332-1337.
27. Schultz KF. Subverting randomization in controlled trials JAMA. 1995:274 1456-1458.
28. Altman DG, Doré CJ. Randomisation and baseline comparisons in clinical trials. Lancet. 1990;335:149-153.
29. Altman DG. Statistics and ethics in medical research. BMJ. 1980;281:1336-1338.
30. Freiman JA, Chalmers TC, Smith H Jr, Kuebler RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. N Engl J Med. 1978;299:690-694.
31. About protocol reviews. [Lancet Interactive Web site] Available at: http:// www.thelancet.com/newlancet/reg/author/protocol1.html. Accessibility verified January 5, 2000.